BrightOwl Loader Loading


Managing Director euraccine Consulting scs and acting as Senior Consultant Business Development at ctl europe and partially with jpt peptide technologies after his time as senior director at the weinberg group. he has key expertise is in the life science sector and Pharmaceutical Research and development. he supports clients in the pharmaceutical, Food and consumer products industries as they seek to develop and manage strategies to optimize their relations with the Biotechnology Industry, in addition to maintaining their existing business. he also assists clients in critical Analysis and design of pre-clinical biocompatibility and efficiency studies, design of clinical protocols, and management of client-sponsored contract research. previously, dr. von hoegen worked at glaxosmithkline biologicals on the pre-clinical and Clinical Development of new innovative Vaccines for viral diseases. he was part of the strategic team that explored new therapeutic approaches for cancer, hiv, hepatitis and hpv. dr. von hoegen received his ph.d. in Immunology from the German Cancer Research center in heidelberg (frg) and completed his Postdoctoral study in molecular Immunology at the stanford University medical center. he frequently serves as an Expert for the eu research directorate-general in the evaluation of research grant proposals. specialties: immunotherapy including Vaccines for infectious disease and cancer. genetherapy and Drug Delivery. Preclinical to early Clinical Development. scientific Leader for a large epidemiological cancer study. identification and management of CRO's and sites (site whisperer). study rescue and Biomarker selection. ec Expert for the evaluation of proposals under fp6, fp7 and horizon 2020. Expert for Innovation fond denmark euripred: workpackage Leader and Member of the steering comittee.


Current Experience

  • CSO /CDO

    Since October 2015

    Co-founder for softvax: to move into poc first in man studies for mucosal prostate Cancer vaccine

    Co-founder for SOFTVAX: to move into POC first in man studies for mucosal prostate cancer vaccine

  • Senior Director Business Development

    Since November 2010

  • Managing Director

    Since September 1998 Managing Director of euraccine consultancy for life science with focus on infectious disease, oncology, Genomics and Proteomics. Translation of Research to Pharmaceutical products (lasne, belgium). network Consultant with consultit (ch), beckmann bio (be), bioventure Consulting (d) and ithaka Lifesciences (uk). Business Development management and scientific Leadership europe for immunotope (, which is a Clinical stage Biotechnology company developing immunotherapy products for the Treatment and prevention of Cancer and chronic viral infections. the products activate the patient’s own immune system to fight disease and prevent recurrence. immunotope’s lead product is the ocpm immunotherapeutic vaccine, a multivalent Cancer therapeutic mixture of twelve different novel antigens, each of which targets a separate, critical pathway known to be present in highly aggressive tumors. Expert for teh evaluation of grant proposals aunder fp6, fp7 and horizon 2020. Managing Director of Euraccine Consultancy for Life Science with focus on Infectious Disease, Oncology, Genomics and Proteomics. Translation of Research to pharmaceutical products (Lasne, Belgium). Network consultant with ConsultIt (CH), Beckmann Bio (Be), Bioventure Consulting (D) and Ithaka Lifesciences (UK). Business Development management and scientific leadership Europe for Immunotope (, which is a clinical stage biotechnology company developing immunotherapy products for the treatment and prevention of cancer and chronic viral infections. The products activate the patient’s own immune system to fight disease and prevent recurrence. Immunotope’s lead product is the OCPM Immunotherapeutic Vaccine, a multivalent cancer therapeutic mixture of twelve different novel antigens, each of which targets a separate, critical pathway known to be present in highly aggressive tumors. Expert for teh evaluation of grant proposals aunder FP6, FP7 and Horizon 2020.

Past Experience

  • Senior Director

    November 2004 --- October 2010

  • Chief Scientific Officer

    January 2002 --- January 2004
    Discovery and Validation of Cancer (colon, breast and lung) markers for Biomarkers, drug targets and vaccine targets integrating Genomics, Proteomics, immunomics and Bioinformatics.

  • Managing Director

    January 1998 --- January 2004

  • Vice President International Operations

    January 2000 --- January 2002

  • CSO

    January 1999 --- January 2001

  • Head Cellular Immunology and Therapeutic Vaccines

    January 1995 --- January 1998
    cellular Immunology, ELISA, elispot, mage vaccine, hpv vaccine

  • Head Cellular Immunology and Cancer

    January 1995 --- January 1998

  • Group Leader

    January 1983 --- January 1995

  • Postdoctoral Researcher

    January 1990 --- January 1991

  • Post Doc, Parnes lab

    January 1988 --- January 1990

  • Diploma Student

    January 1981 --- January 1983


Self Assessment :
Analytical thinkingCollaborationCreative thinkingDiligenceFlexibilityInnovative thinkingProactivityProblem solvingService orientedWillingness to compromise


Self Assessment :
Animal models Cell biology Negotiation Phase I R&DAllergy and immunologyAnimal ModelsAnimal trialAntibodiesAssay developmentAuditingBiological Drug DevelopmentBiomarkersBiomedical SciencesBiopharmaceuticalsBiotechnologieBiotechnologyBudget ManagementBudget NegotiationBusiness DevelopmentBusiness IntelligenceCancerCancer ResearchCell Based AssaysCell CultureCellular Product DevelopmentChange ManagementClinical DevelopmentClinical monitoringClinical researchClinical Study DesignClinical trial managementCoachingCross-functional team leadershipDNADue DiligenceEarly development stageELISAEnglishEntrepreneurshipEnzyme-linked immunosorbent assay (ELISA)EpidemiologyEthics submission and approval processExperimentationFACSFlow CytometryGeneticsGenomicsGermanGood Clinical Practice (GCP)Good Laboratory Practice (GLP)Good Manufacturing Practice (GMP)Grant PreparationGXPGynecologic oncologyHealthcare industryImmunoassaysImmunofluorescenceImmunohistochemistryImmunocytochemistry (ICC)Immunohistochemistry (IHC)ImmunologyImmunoprecipitationIn VitroIn vitro diagnostics (IVD)In VivoInductively coupled plasma mass spectrometry (ICP-MS)Infectious diseasesInflammationInterpret clinical trial resultsInternational Project ManagementKOL managementLaboratory ManagementLaboratory ResearchLaboratory study designLeadershipLife SciencesmanagementManagement ConsultingMarketingMarket researchMedical oncology Microsoft ExcelMicrosoft OfficeMicrosoft PowerpointMicrosoft Wordmolecular biologyNegotiationNew Business DevelopmentOncology Clinical ResearchOutsourcingOutlookPatient recruitmentpeople managementPeptidesPharmaceutical IndustryPharmaceutical ResearchPhase IPhase IIIPhase IVPhase IIPhases of clinical development (phase I to IV)Pre-clinical researchPreclinical regulations and practicesPresentation SkillsPresentationsProblem-solving methods and troubleshootingProgram ManagementProject CoordinationProject ManagementProject PlanningProject Portfolio ManagementProteomicsPublic SpeakingPulmonary diseasesR&DR&DRegulatory StrategiesResearchSafety concerns (such as therapeutic ratio with respect to possible adverse effects)Sales ManagementScientific CommunicationsScientific methodologyStart-upsStrategyTeam LeadershipTeam ManagementTeamworkTechnical reportsTechnology transferTime ManagementTransfectionTranslationTranslational MedicineTroubleshootingUnderstand how results translate to practiceUnderstand levels of research evidenceUnderstanding of regulatory guidelinesVaccines
LinkedIn Assessment :
VaccinesInfectious diseasesClinical DevelopmentCancerImmunologyBiotechnologyBiomarkersLife SciencesoncologyClinical researchVirologyClinical trial managementMonoclonal AntibodiesPeptidesImmune monitoringCellular ImmunityProteomicsPharmaceuticalsBiopharmaceuticalsTranslational ResearchTherapeuticsTechnology transferTranslational MedicineR&DLifesciencesPharmaceutical IndustryCTMSELISADrug DevelopmentClinical trialsDrug DiscoveryAntibodiesmolecular biologyRegulatory affairsCROGenomicsTherapistsToxicologyCancer ResearchCellProtein chemistryBioinformaticsValidationBiomarker DiscoveryPharmaceuticsLaboratoryDrug DeliveryEpidemiologyBiochemistryBusiness Development

Skills and Expertise

Self Assessment :
Analytical skills Develop clinical trial protocols Monitor a clinical study Report data Search literature on clinical trials Technology research Write papersAssign activitiesAssist with experimentsBiomarker Researchbudgeting of R&D activitiesCoachCoach staffCollaborate with medical teamCollaborate with PI and institution to respond to any audit findings and implement-approved recommendations.Collaborate with project teamConduct animal studiesConduct maintenance visitsConduct post-marketing surveillance studyConduct research at universitiesConduct university research Coordinate ethics committeeCoordinate projectsCoordinate regular advisory boardCoordinate with the ethics commiteecoordinating research projectsDesign scientific projects (in biology)Develop business planDevelop clinical strategyDevelop clinical hypothesesDirect co-workers to achieve resultEstablish professional relationships with partnersEvaluate protocolsLiaise with professionals in other divisions of the company as requiredLiaise with doctors and other professionals throughout the studyLiaise with doctorsLead teamsLead studiesLiaise with research teamLiaise with research team in order to accurately collect and record datalifescienceManuscript preparationManuscript preparation and reviewManuscript reviewNegotiate protocol details Negotiate budget NegotiationNetworkObtain grantsOral presentationOrganise steering committeeOrganize scientific projects (in biology)People managementproject managementProvide medical rationale of diseasePublication of articlesPublish scientific projectsR&DRead medical literatureRead medical literature to maintain current awareness and knowledgeResearch at universitiesReview protocolsSupervise PhD studentsSupervise techniciansWork with coordination and data management teams


  • Post Doc in Immunology from Stanford University School of Medicine in 1990
  • Diploma in Immunology from Universität zu Köln in 1983

Training and Certification

  • exec MBA training in 2001 Training
  • PhD in 1986 Certification
  • Diploma in Biology in 1983 Certification
  • Master in Biology in 1980 Certification


BrightOwl Assessment:
Self Assessment:
Full Proficiency
Professional Proficiency
Elementary Proficiency
Elementary Proficiency
Elementary Proficiency

Work Preferences

  • Notice Period:
    12 weeks
  • Positions I am interested in:
    Associate Director - Head of Preclinical Immunology - Bacterial Vaccines Business Consultant Chief Strategy Officer Clinical Project Leader CSO Lead Consultant Manager Managing Director Senior Consultant
  • Locations I am interested in:
    Belgium Germany Netherlands Switzerland
  • Work From Home:
    Yes, 0 to 5 days per week
  • Work Regime:
    Permanent position
    BrightOwl freelancer :    10 Hours per week
  • International:

Area / Region

Lasne, Belgium


Driving License
  • Yes

Similar Candidates

Other Candidates in Belgium

Other Candidates in Lasne

Other similar Candidates in Lasne

Other Candidates

Most Recent Searches

Most Famous Searches

You might also like